Azetidines of pharmacological interest
Deepa R Parmar
1, 2
,
Jigar Y Soni
1
,
Ramakrishna Guduru
2
,
Rahul H Rayani
1, 2
,
Rakesh V Kusurkar
1, 2
,
Anand Vala
1, 2
1
Department of Chemistry, Faculty of Basic and Applied Science Madhav University Sirohi Rajasthan India
|
2
Piramal Pharma Limited–Discovery Solutions Ahmedabad Gujarat India
|
Publication type: Journal Article
Publication date: 2021-06-29
scimago Q2
wos Q2
SJR: 0.571
CiteScore: 7.0
Impact factor: 3.6
ISSN: 03656233, 15214184
PubMed ID:
34184778
Drug Discovery
Pharmaceutical Science
Abstract
Azetidines are almost unexplored among nitrogen-containing saturated heterocycles due to difficulties associated with their synthesis. However, over the past few years, attempts have been made by scientists to advance their synthetic feasibility. Compounds with the azetidine moiety display an important and diverse range of pharmacological activities, such as anticancer, antibacterial, antimicrobial, antischizophrenic, antimalarial, antiobesity, anti-inflammatory, antidiabetic, antiviral, antioxidant, analgesic, and dopamine antagonist activities, and are also useful for the treatment of central nervous system disorders and so forth. Owing to its satisfactory stability, molecular rigidity, and chemical and biological properties, azetidine has emerged as a valuable scaffold and it has drawn the attention of medicinal researchers. The present review sheds light on the traditional method of synthesis of azetidine and advancements in synthetic methodology over the past few years, along with its application with various examples, and its biological significance.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
8
9
|
|
|
Angewandte Chemie
9 publications, 12.5%
|
|
|
Angewandte Chemie - International Edition
9 publications, 12.5%
|
|
|
Journal of the American Chemical Society
7 publications, 9.72%
|
|
|
ACS Catalysis
6 publications, 8.33%
|
|
|
Organic and Biomolecular Chemistry
3 publications, 4.17%
|
|
|
Organic Letters
3 publications, 4.17%
|
|
|
Tetrahedron Letters
3 publications, 4.17%
|
|
|
Chemical Communications
2 publications, 2.78%
|
|
|
Journal of Organic Chemistry
2 publications, 2.78%
|
|
|
Nature Catalysis
2 publications, 2.78%
|
|
|
COVID
1 publication, 1.39%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 1.39%
|
|
|
Journal of Molecular Structure
1 publication, 1.39%
|
|
|
Tetrahedron Green Chem
1 publication, 1.39%
|
|
|
Journal of Heterocyclic Chemistry
1 publication, 1.39%
|
|
|
European Journal of Organic Chemistry
1 publication, 1.39%
|
|
|
Frontiers in Chemistry
1 publication, 1.39%
|
|
|
Archiv der Pharmazie
1 publication, 1.39%
|
|
|
Journal of Physical Chemistry C
1 publication, 1.39%
|
|
|
Chemistry - An Asian Journal
1 publication, 1.39%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 1.39%
|
|
|
Tetrahedron
1 publication, 1.39%
|
|
|
Russian Journal of Organic Chemistry
1 publication, 1.39%
|
|
|
Russian Journal of General Chemistry
1 publication, 1.39%
|
|
|
Renewable and Sustainable Energy Reviews
1 publication, 1.39%
|
|
|
Asian Journal of Organic Chemistry
1 publication, 1.39%
|
|
|
Chemistry - A European Journal
1 publication, 1.39%
|
|
|
Organic Chemistry Frontiers
1 publication, 1.39%
|
|
|
Chinese Chemical Letters
1 publication, 1.39%
|
|
|
Advanced Synthesis and Catalysis
1 publication, 1.39%
|
|
|
1
2
3
4
5
6
7
8
9
|
Publishers
|
5
10
15
20
25
30
|
|
|
Wiley
26 publications, 36.11%
|
|
|
American Chemical Society (ACS)
19 publications, 26.39%
|
|
|
Elsevier
10 publications, 13.89%
|
|
|
Royal Society of Chemistry (RSC)
6 publications, 8.33%
|
|
|
Springer Nature
5 publications, 6.94%
|
|
|
Pleiades Publishing
2 publications, 2.78%
|
|
|
MDPI
1 publication, 1.39%
|
|
|
Frontiers Media S.A.
1 publication, 1.39%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.39%
|
|
|
Georg Thieme Verlag KG
1 publication, 1.39%
|
|
|
5
10
15
20
25
30
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
72
Total citations:
72
Citations from 2024:
53
(73%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Parmar D. R. et al. Azetidines of pharmacological interest // Archiv der Pharmazie. 2021. Vol. 354. No. 11. p. 2100062.
GOST all authors (up to 50)
Copy
Parmar D. R., Soni J. Y., Guduru R., Rayani R. H., Kusurkar R. V., Vala A. Azetidines of pharmacological interest // Archiv der Pharmazie. 2021. Vol. 354. No. 11. p. 2100062.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1002/ardp.202100062
UR - https://doi.org/10.1002/ardp.202100062
TI - Azetidines of pharmacological interest
T2 - Archiv der Pharmazie
AU - Parmar, Deepa R
AU - Soni, Jigar Y
AU - Guduru, Ramakrishna
AU - Rayani, Rahul H
AU - Kusurkar, Rakesh V
AU - Vala, Anand
PY - 2021
DA - 2021/06/29
PB - Wiley
SP - 2100062
IS - 11
VL - 354
PMID - 34184778
SN - 0365-6233
SN - 1521-4184
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Parmar,
author = {Deepa R Parmar and Jigar Y Soni and Ramakrishna Guduru and Rahul H Rayani and Rakesh V Kusurkar and Anand Vala},
title = {Azetidines of pharmacological interest},
journal = {Archiv der Pharmazie},
year = {2021},
volume = {354},
publisher = {Wiley},
month = {jun},
url = {https://doi.org/10.1002/ardp.202100062},
number = {11},
pages = {2100062},
doi = {10.1002/ardp.202100062}
}
Cite this
MLA
Copy
Parmar, Deepa R., et al. “Azetidines of pharmacological interest.” Archiv der Pharmazie, vol. 354, no. 11, Jun. 2021, p. 2100062. https://doi.org/10.1002/ardp.202100062.